J
Juan F. Alcala-Diaz
Researcher at University of Córdoba (Spain)
Publications - 90
Citations - 2930
Juan F. Alcala-Diaz is an academic researcher from University of Córdoba (Spain). The author has contributed to research in topics: Mediterranean diet & Medicine. The author has an hindex of 22, co-authored 73 publications receiving 1923 citations. Previous affiliations of Juan F. Alcala-Diaz include Carlos III Health Institute & Sofia University.
Papers
More filters
Journal ArticleDOI
Intestinal Microbiota Is Influenced by Gender and Body Mass Index.
Carmen Haro,Carmen Haro,Oriol A. Rangel-Zuñiga,Oriol A. Rangel-Zuñiga,Juan F. Alcala-Diaz,Juan F. Alcala-Diaz,Francisco Gomez-Delgado,Francisco Gomez-Delgado,Pablo Perez-Martinez,Pablo Perez-Martinez,Javier Delgado-Lista,Javier Delgado-Lista,Gracia M. Quintana-Navarro,Gracia M. Quintana-Navarro,Blanca B. Landa,Juan A Navas-Cortes,Manuel Tena-Sempere,Manuel Tena-Sempere,Jose C. Clemente,Jose Lopez-Miranda,Jose Lopez-Miranda,Francisco Pérez-Jiménez,Francisco Pérez-Jiménez,Antonio Camargo,Antonio Camargo +24 more
TL;DR: The results suggest that gut microbiota may differ between men and women, and that these differences may be influenced by the grade of obesity, as a function of gender and changes in body mass index.
Journal ArticleDOI
Monounsaturated Fatty Acid–Enriched High-Fat Diets Impede Adipose NLRP3 Inflammasome–Mediated IL-1β Secretion and Insulin Resistance Despite Obesity
Orla M. Finucane,Claire L. Lyons,Aoife M. Murphy,Clare M. Reynolds,Rut Klinger,Niamh P. Healy,Aoife A. Cooke,Rebecca C. Coll,Liam McAllan,Kanishka N. Nilaweera,M. O'Reilly,Audrey C. Tierney,Melissa J. Morine,Juan F. Alcala-Diaz,Jose Lopez-Miranda,Darran P. O'Connor,Luke A. J. O'Neill,Fiona C. McGillicuddy,Helen M. Roche +18 more
TL;DR: In vitro, it is demonstrated that the MUFA oleic acid can impede ATP-induced IL-1β secretion from lipopolysaccharide- and SFA-primed cells in an AMPK-dependent manner and suggest that dietary MUFA can attenuate IL- 1β–mediated insulin resistance and adipose dysfunction despite obesity via the preservation of AMPK activity.
Journal ArticleDOI
Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population.
Carmen Haro,Carmen Haro,Miguel Montes-Borrego,Oriol A. Rangel-Zuñiga,Oriol A. Rangel-Zuñiga,Juan F. Alcala-Diaz,Juan F. Alcala-Diaz,Francisco Gomez-Delgado,Francisco Gomez-Delgado,Pablo Perez-Martinez,Pablo Perez-Martinez,Javier Delgado-Lista,Javier Delgado-Lista,Gracia M. Quintana-Navarro,Gracia M. Quintana-Navarro,Francisco J. Tinahones,Blanca B. Landa,Jose Lopez-Miranda,Jose Lopez-Miranda,Antonio Camargo,Antonio Camargo,Francisco Pérez-Jiménez +21 more
TL;DR: It is suggested that long-term consumption of the Med and LFHCC diets exerts a protective effect on the development of type 2 diabetes by different specific changes in the gut microbiota, increasing the abundance of the Roseburia genus and F. prausnitzii, respectively.
Journal ArticleDOI
The gut microbial community in metabolic syndrome patients is modified by diet
Carmen Haro,Carmen Haro,Sonia García-Carpintero,Sonia García-Carpintero,Juan F. Alcala-Diaz,Juan F. Alcala-Diaz,Francisco Gomez-Delgado,Francisco Gomez-Delgado,Javier Delgado-Lista,Javier Delgado-Lista,Pablo Perez-Martinez,Pablo Perez-Martinez,Oriol A. Rangel Zuñiga,Oriol A. Rangel Zuñiga,Gracia M. Quintana-Navarro,Gracia M. Quintana-Navarro,Blanca B. Landa,Jose C. Clemente,Jose Lopez-Miranda,Jose Lopez-Miranda,Antonio Camargo,Antonio Camargo,Francisco Pérez-Jiménez,Francisco Pérez-Jiménez +23 more
TL;DR: The results suggest that the Mediterranean diet could be a useful tool to restore potentially beneficial members of the gut microbiota, although the stability of these changes over time still remains to be assessed.
Journal ArticleDOI
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fat diet on cardiovascular disease in coronary patients.
Javier Delgado-Lista,Javier Delgado-Lista,Pablo Perez-Martinez,Pablo Perez-Martinez,Antonio Garcia-Rios,Antonio Garcia-Rios,Juan F. Alcala-Diaz,Juan F. Alcala-Diaz,Ana I. Perez-Caballero,Ana I. Perez-Caballero,Francisco Gomez-Delgado,Francisco Gomez-Delgado,Francisco Fuentes,Francisco Fuentes,Gracia M. Quintana-Navarro,Gracia M. Quintana-Navarro,Fernando López-Segura,Fernando López-Segura,Ana M Ortiz-Morales,Ana M Ortiz-Morales,Nieves Delgado-Casado,Nieves Delgado-Casado,Elena M. Yubero-Serrano,Elena M. Yubero-Serrano,Antonio Camargo,Antonio Camargo,Carmen Marin,Carmen Marin,Fernando Rodriguez-Cantalejo,Purificacion Gomez-Luna,Purificacion Gomez-Luna,Jose M. Ordovas,Jose Lopez-Miranda,Jose Lopez-Miranda,Francisco Pérez-Jiménez,Francisco Pérez-Jiménez +35 more
TL;DR: The Coronary Diet Intervention with Olive oil and cardiovascular PREVention study (CORDIOPREV study, clinical trials number NCT00924937) is to compare the ability of a Mediterranean diet rich in virgin olive oil versus a low-fat diet to influence the composite incidence of cardiovascular events after 7 years in subjects with documented coronary heart disease at baseline.